Ajinomoto expands fill-finish capacity

By The Science Advisory Board staff writers

May 25, 2021 -- Ajinomoto Bio-Pharma Services is opening a high-speed, multipurpose fill-finish line in its commercial manufacturing facility located in San Diego, CA.

The fill line, operational this summer, will offer a range of configurations including prefilled syringes, cartridges, and vials with ready-to-use components to minimize component preparation and packaging. The fill suite also houses two formulation suites, one of which is capable of handling flammable (class H) compounds.

Ajinomoto's Optima line uses Skan isolated barrier technology to guarantee the required sterility for fill finish and offers flexibility to meet current good manufacturing practices for clinical and commercial drugs, while in commercial compliance with the U.S. Food and Drug Administration. The high-speed process can move 22,000 syringes per hour through the line, with a batch capacity of over 200,000 syringes.


Copyright © 2021 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here